2003Zhōnghuá yàoxué zázhìRequires access

Studies on the pharmacokinetics and bioequivalence of domestic rosiglizole tablet in healthy volunteers

Zhou Yan-wen

Open publisher page 0 citations

Abstract

OBJECTIVE To study the bioavailability of domestic rosiglizole tablet and imported maleate rosiglizole tablet in healthy volunteers.METHODS A single oral dose of 8 mg test or reference preparations was given to 22 healthy male volunteers in a randomized crossover study.The serum concentrations of rosiglizole were determined by reversed HPLC with the fluorescence detector.RESULTS The main pharmacokinetics of the two products were as follow:t max (1.27±0.53) and (1.18±0.48) h,c max ( 425.35±80.55) and (462.01±132.95) μg·L -1;t 1/2β(4.08±1.00) and (3.93±0.68) h;AUC 0~24 (1 774.60±588.91) and ( 1 770.04±604.10) μg·h·L -1,respectively.The relative bioavailability of the test to reference tablets was(103.47±23.35)%.CONCLUSION The results of statistic analysis showed that the domestic rosiglizole tablet and imported maleate rosiglizole tablet were bioquivalent.

About this research paper

What this paper is about

OBJECTIVE To study the bioavailability of domestic rosiglizole tablet and imported maleate rosiglizole tablet in healthy volunteers.METHODS A single oral dose of 8 mg test or reference preparations was given to 22 healthy male volunteers in a randomized crossover study.The serum concentrations of rosiglizole were determined by reversed HPLC with the fluorescence detector.RESULTS The main pharmacokinetics of the two products were as follow:t max (1.27±0.53) and (1.18±0.48) h,c max ( 425.35±80.55) and (462.01±132.95) μg·L -1;t 1/2β(4.08±1.00) and (3.93±0.68) h;AUC 0~24 (1 774.60±588.91) and ( 1 770.04±604.10) μg·h·L -1,respectively.The relative bioavailability of the test to reference tablets was(103.47±23.35)%.CONCLUSION The results of statistic analysis showed that the domestic rosiglizole tablet and imported maleate rosiglizole tablet were bioquivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the bioavailability of domestic rosiglizole tablet and imported maleate rosiglizole tablet in healthy volunteers.METHODS A single oral dose of 8 mg test or reference preparations was given to 22 healthy male volunteers in a randomized crossover study.The serum concentrations of rosiglizole were determined by reversed HPLC with the fluorescence detector.RESULTS The main pharmacokinetics of the two products were as follow:t max (1.27±0.53) and (1.18±0.48) h,c max ( 425.35±80.55) and (462.01±132.95) μg·L -1;t 1/2β(4.08±1.00) and (3.93±0.68) h;AUC 0~24 (1 774.60±588.91) and ( 1 770.04±604.10) μg·h·L -1,respectively.The relative bioavailability of the test to reference tablets was(103.47±23.35)%.CONCLUSION The results of statistic analysis showed that the domestic rosiglizole tablet and imported maleate rosiglizole tablet were bioquivalent.

Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Crossover study, Pharmacology, Medicine, High-performance liquid chromatography, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on the pharmacokinetics and bioequivalence of domestic rosiglizole tablet in healthy volunteers — Research Paper | ScholarLens